Showing 12 of 12 recruiting trials for “Neuroendocrine tumor of pancreas”
Pancreatic Neuroendocrine Tumour - Optimal Surgical Debulking or Not
Patients With High-grade Pancreatic Neuroendocrine Tumors
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
Study to Test the Combination of Fulvestrant With Lu-DOTATATE for Advanced Pancreatic Neuroendocrine Tumors
Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine Tumors
👨⚕️ Nikolaos Trikalinos, Yale University Cancer Center LAO📍 10 sites📅 Started Aug 2024View details ↗
RecruitingNCT06121622 ↗
Development of New Personalised 3D Preclinical Models of Pancreatic Neuroendocrine Tumours
Trial of Nab-sirolimus in Patients With Well-differentiated Neuroendocrine Tumors (NETs) of the Gastrointestinal Tract, Lung, or Pancreas Who Have Not Received Prior Treatment With mTOR Inhibitors
RecruitingNCT05847855 ↗
Plasma cfDNA Fragmentomics for Early pNET Detection and Differential Diagnosis of Solid Pancreatic Tumors
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors
Precision Radiotherapy Using MR-linac for Pancreatic Neuroendocrine Tumours in MEN1 Patients
Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy
Pancreatic Radiofrequency Under High Echo-endoscopy in the Management of Pancreatic Neuroendocrine Tumors
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →